- Shantha Biologics has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India.
- The collaboration will be conducted under agreed contractual terms and in accordance with applicable quality, compliance, and regulatory requirements.
Shantha Biologics has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India. The agreement expands the company’s role in supporting pharmaceutical manufacturing through specialized fill-finish operations.
According to the companies, the collaboration will be carried out under an agreed contractual framework and in accordance with applicable quality, compliance, and regulatory requirements. No financial terms or additional details of the agreement were disclosed.
The agreement reflects Shantha Biologics’ continued focus on manufacturing execution and its role in supporting global healthcare companies through contract manufacturing services. The company said the partnership will emphasize operational execution while maintaining quality and compliance standards.
“We are pleased to enter into this collaboration, which reflects the confidence placed in Shantha Biologics’ capabilities and our commitment to reliable, high-quality cartridge fill-finish services.”
Vishy Chebrol, Director of Shantha Biologics
Shantha Biologics said it looks forward to supporting the collaboration through its cartridge fill-finish manufacturing capabilities while meeting the agreed quality and regulatory requirements.
